rs147699855

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006329.4(FBLN5):​c.620-8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000765 in 1,612,438 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00052 ( 4 hom. )

Consequence

FBLN5
NM_006329.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00002825
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.42

Publications

0 publications found
Variant links:
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • cutis laxa, autosomal recessive, type 1A
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp
  • Charcot-Marie-Tooth disease, demyelinating, IIA 1H
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • macular degeneration, age-related, 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensorimotor neuropathy with hyperelastic skin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive cutis laxa type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 14-91887320-A-G is Benign according to our data. Variant chr14-91887320-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006329.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBLN5
NM_006329.4
MANE Select
c.620-8T>C
splice_region intron
N/ANP_006320.2
FBLN5
NM_001384158.1
c.743-8T>C
splice_region intron
N/ANP_001371087.1G3XA98
FBLN5
NM_001384159.1
c.671-8T>C
splice_region intron
N/ANP_001371088.1G3V4U0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBLN5
ENST00000342058.9
TSL:1 MANE Select
c.620-8T>C
splice_region intron
N/AENSP00000345008.4Q9UBX5
FBLN5
ENST00000267620.14
TSL:1
c.743-8T>C
splice_region intron
N/AENSP00000267620.10G3XA98
FBLN5
ENST00000556154.5
TSL:1
c.671-8T>C
splice_region intron
N/AENSP00000451982.2G3V4U0

Frequencies

GnomAD3 genomes
AF:
0.00309
AC:
470
AN:
151990
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00952
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00269
Gnomad ASJ
AF:
0.00520
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00209
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00121
AC:
304
AN:
250476
AF XY:
0.00105
show subpopulations
Gnomad AFR exome
AF:
0.00794
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.00447
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000521
AC:
761
AN:
1460330
Hom.:
4
Cov.:
32
AF XY:
0.000483
AC XY:
351
AN XY:
726496
show subpopulations
African (AFR)
AF:
0.00881
AC:
295
AN:
33478
American (AMR)
AF:
0.00103
AC:
46
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00448
AC:
117
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39686
South Asian (SAS)
AF:
0.00184
AC:
159
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52106
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000450
AC:
50
AN:
1111826
Other (OTH)
AF:
0.00147
AC:
89
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00310
AC:
472
AN:
152108
Hom.:
2
Cov.:
31
AF XY:
0.00281
AC XY:
209
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00957
AC:
397
AN:
41498
American (AMR)
AF:
0.00268
AC:
41
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00520
AC:
18
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00188
AC:
9
AN:
4784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
67982
Other (OTH)
AF:
0.00142
AC:
3
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00181
Hom.:
1
Bravo
AF:
0.00346
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
Cutis laxa (1)
-
-
1
FBLN5-related disorder (1)
-
-
1
Macular degeneration, age-related, 3 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
14
DANN
Benign
0.61
PhyloP100
2.4
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000028
dbscSNV1_RF
Benign
0.022
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147699855; hg19: chr14-92353664; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.